The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Life Saving Drugs Program – Hereditary tyrosinaemia (type 1) – Reapplication

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for hereditary tyrosinaemia (type 1).

Downloads

Life Saving Drugs Program – Hereditary tyrosinaemia (type 1) – Reapplication

We are working to improve this form, which currently does not display correctly in all web browsers. In the meantime, you can use the PDF version by:

  • Saving the PDF to your hard drive and opening it with your PDF software. You can then type into the fields before printing, signing and returning to us

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Form
Audience:
Health sector
Language:
English
Description:

This form includes:

  • patient eligibility checklist
  • privacy notice and patient consent
  • dosing details
  • treating physician’s declaration
  • reapplication checklist.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.